Marrone Bio Innovations to Present at H.C. Wainwright 22nd Annual Global Investment Conference
September 10 2020 - 8:31AM
Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio” or the
“Company”), an international leader in providing growers with
sustainable bioprotection and plant health solutions to support
global agricultural needs, today announced that management will
present at the H.C. Wainwright 22nd Annual Global Investment
Conference taking place virtually September 14 – 16, 2020.
Jim Boyd, Chief Financial Officer, is scheduled
to host a virtual presentation during the conference as follows and
will participate in one-on-one meetings with Chief Executive
Officer Kevin Helash throughout the day.
H.C. Wainwright 22nd Annual Global Investment
ConferenceDate: Monday, September 14, 2020 Time: 11:30
a.m. Eastern time (8:30 a.m. Pacific time) Webcast:
https://wsw.com/webcast/hcw7/mbii/1589721
A live audio webcast and archive of the
conference presentation will be available using the webcast link
above. For more information on the H.C. Wainwright 22nd Annual
Global Investment Conference or to schedule a one-on-one meeting
with management, please contact your H.C. Wainwright
representative.
About Marrone
Bio InnovationsMarrone Bio Innovations Inc.
(NASDAQ: MBII) is a growth-oriented company leading the movement to
a more sustainable world through the discovery, development and
sale of innovative biological products for crop protection, plant
health and waterway systems treatment that help customers operate
more sustainably while increasing their return on investment. MBI
has screened over 18,000 microorganisms and 350 plant extracts,
leveraging its in-depth knowledge of plant and soil microbiomes
enhanced by advanced molecular technologies and natural product
chemistry to rapidly develop seven product lines. Supported by a
robust portfolio of over 400 issued and pending patents, MBI’s
currently available commercial products are Regalia®, Stargus®,
Grandevo®, Venerate®, Majestene®, Haven®, Pacesetter™, Zelto® Jet
Oxide® and Jet Ag® and Zequanox®, with a next-generation
insecticide-nematicide, a breakthrough bioherbicide and a
biofumigant in the Company’s product pipeline. MBI’s Pro Farm
Finland-based subsidiary employs a proprietary technology derived
from wood waste to stimulate plant growth and improve plant health,
resulting in improved yields and crop quality. Products include
UBP™ 110, Foramin®, UBP™ Seed Treatment, Foramin® ST. Learn more
about Marrone Bio Innovations at www.marronebio.com. We also use
our investor relations website, https://investors.marronebio.com,
as well as our corporate Twitter account, @Marronebio, as means of
disclosing material non-public information, and encourage our
investors and others to monitor and review the information we make
public in these locations. Follow us on social media: Twitter,
LinkedIn and Instagram.
Marrone Bio Innovations
Forward Looking StatementsThis press release contains
forward-looking statements that involve substantial risks and
uncertainties. All statements, other than statements of historical
facts, included in this press release regarding strategy, future
operations and plans, including assumptions underlying such
statements, are forward-looking statements, and should not be
relied upon as representing MBI’s views as of any subsequent
date. Examples of such statements include statements regarding
the timing of Helash’s employment and appointment to the company’s
board of directors and the company’s goals for future performance.
Such forward-looking statements are based on information available
to the Company as of the date of this release and involve a number
of risks and uncertainties, some beyond the Company’s control, that
could cause actual results to differ materially from those
anticipated by these forward-looking statements, including the
recent uncertainty in the global economy and industry-specific
economy caused by the COVID-19 pandemic, consumer, regulatory and
other factors affecting demand for the Company’s products, weather,
regulatory and other factors affecting demand for the MBI’s
products, any difficulty in marketing MBI’s products in its target
markets, competition in the market for pest management products,
lack of understanding of bio-based pest management products by
customers and growers, and adverse decisions by regulatory agencies
and other relevant third parties. Additional information that could
lead to material changes in MBI’s performance is contained in its
filings with the SEC. MBI is under no obligation to, and expressly
disclaims any responsibility to, update or alter forward-looking
statements contained in this release, whether as a result of
current information, future events or otherwise.
Investor Relations Contact: Greg Falesnik or
Luke Zimmerman MZ Group – MZ North America Phone: 949-385-6449
MBII@mzgroup.us
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Mar 2024 to Apr 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Apr 2023 to Apr 2024